These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26337518)

  • 1. Improved Alertness Is Associated with Early Increase in Serum Brain-Derived Neurotrophic Factor and Antidepressant Treatment Outcome in Major Depression.
    Mikoteit T; Hemmeter U; Eckert A; Brand S; Bischof R; Delini-Stula A; Holsboer-Trachsler E; Beck J
    Neuropsychobiology; 2015; 72(1):16-28. PubMed ID: 26337518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression.
    Mikoteit T; Beck J; Eckert A; Hemmeter U; Brand S; Bischof R; Holsboer-Trachsler E; Delini-Stula A
    Psychopharmacology (Berl); 2014 Aug; 231(15):2955-65. PubMed ID: 24562062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study.
    Tadić A; Wagner S; Schlicht KF; Peetz D; Borysenko L; Dreimüller N; Hiemke C; Lieb K
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):415-20. PubMed ID: 20732374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between serum BDNF and the antidepressant effect of acute exercise in depressed women.
    Meyer JD; Koltyn KF; Stegner AJ; Kim JS; Cook DB
    Psychoneuroendocrinology; 2016 Dec; 74():286-294. PubMed ID: 27697714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients.
    Gonul AS; Akdeniz F; Taneli F; Donat O; Eker C; Vahip S
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):381-6. PubMed ID: 15809771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
    Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
    Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF plasma levels variations in major depressed patients receiving duloxetine.
    Fornaro M; Escelsior A; Rocchi G; Conio B; Magioncalda P; Marozzi V; Presta A; Sterlini B; Contini P; Amore M; Fornaro P; Martino M
    Neurol Sci; 2015 May; 36(5):729-34. PubMed ID: 25501804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.
    Raskin J; Wiltse CG; Siegal A; Sheikh J; Xu J; Dinkel JJ; Rotz BT; Mohs RC
    Am J Psychiatry; 2007 Jun; 164(6):900-9. PubMed ID: 17541049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report.
    Grassi-Oliveira R; Stein LM; Lopes RP; Teixeira AL; Bauer ME
    Biol Psychiatry; 2008 Aug; 64(4):281-5. PubMed ID: 18406398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological approach to brain-derived neurotrophic factor plasma levels in major depressed patients receiving duloxetine.
    Agilli M; Aydin FN
    Neurol Sci; 2015 Jun; 36(6):1061-2. PubMed ID: 25637063
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment response and cognitive impairment in major depression: association with C-reactive protein.
    Chang HH; Lee IH; Gean PW; Lee SY; Chi MH; Yang YK; Lu RB; Chen PS
    Brain Behav Immun; 2012 Jan; 26(1):90-5. PubMed ID: 21839826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
    Ricken R; Adli M; Lange C; Krusche E; Stamm TJ; Gaus S; Koehler S; Nase S; Bschor T; Richter C; Steinacher B; Heinz A; Rapp MA; Borgwardt S; Hellweg R; Lang UE
    J Clin Psychopharmacol; 2013 Dec; 33(6):806-9. PubMed ID: 24018547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
    Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
    Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between health related quality of life and severity of depression in patients with major depressive disorder].
    Cao Y; Li W; Shen J; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):143-8. PubMed ID: 21368424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment.
    Engelmann J; Wagner S; Wollschläger D; Kaaden S; Schlicht KF; Dreimüller N; Braus DF; Müller MB; Tüscher O; Frieling H; Tadić A; Lieb K
    Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):183-193. PubMed ID: 30929060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression.
    Gorgulu Y; Caliyurt O
    Brain Res Bull; 2009 Sep; 80(3):158-62. PubMed ID: 19576267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study.
    Spronk D; Arns M; Barnett KJ; Cooper NJ; Gordon E
    J Affect Disord; 2011 Jan; 128(1-2):41-8. PubMed ID: 20619899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Working memory disturbances in patients with major depression after ECT treatment].
    Datka W; Siwek M; Dudek D; Maczka G; Zieba A
    Psychiatr Pol; 2007; 41(3):339-49. PubMed ID: 17900050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.